Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users

References

• National Conference of State Legislatures. State medical marijuana laws. 2012. Available from: http://www.ncsl.org/issues-research/health/state-medical-marijuana-laws.aspx [last accessed 20 May 2013]
   Google Scholar
• Cerdá M, Wall M, Keyes KM, Galea S, Hasin D. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse, and dependence. Drug Alcohol Depend 2012;120:22–27
   PubMed Web of Science ®Google Scholar
• Nunberg H, Kilmer B, Pacula R, Burgdorf J. An analysis of applicants presenting to a medical marijuana specialty practice in California. J Drug Policy Anal 2011;4:pii:1--16
   Google Scholar
• O’Connell T, Bou-Matar C. Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduct J 2007;4:16
   PubMedGoogle Scholar
• Reiman A. Medical cannabis patients: patient profiles and health care utilization patterns. J Evid Based Complementary Altern Med 2007;12:31–50
   Google Scholar
• Reiman A. Cannabis as a substitute for alcohol and other drugs. Harm Reduct J 2009;6:35
   PubMed Web of Science ®Google Scholar
• Reinarman C, Nunberg H, Lanthier F, Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs 2011;43:128–135
   PubMed Web of Science ®Google Scholar
• Harris D, Jones RT, Shank R, Nath R, Fernandez E, Goldstein K, Mendelson J. Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. J Addict Dis 2000;19:89–103
   PubMed Web of Science ®Google Scholar
• Tambaro S, Bortolato M. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. Recent Pat CNS Drug Discov 2012;7:25–40
   PubMedGoogle Scholar
• Noyes R, Brunk S, Baram D, Canter A. Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Psychopharmacol 1975;15:139–143
   Google Scholar
• Wallace M, Schulteis G, Atkinson J, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 2007;107:785–796
   PubMed Web of Science ®Google Scholar
• Ware M, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, Gamsa A, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:694–701
   PubMed Web of Science ®Google Scholar
• Bonn-Miller M, Vujanovic A, Drescher K. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol Addict Behav 2011;25:485–491
   PubMed Web of Science ®Google Scholar
• Buckner J, Heimberg R, Schneier F, Liu S, Wang S, Blanco C. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2012;124:128–134
   PubMed Web of Science ®Google Scholar
• Cougle J, Bonn-Miller M, Vujanovic A, Zvolensky M, Hawkins K. Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychol Addict Behav 2011;25:554–558
   PubMed Web of Science ®Google Scholar
• Crippa J, Zuardi A, Martin-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 2009;24:515–523
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003;98:1493–1504
   PubMed Web of Science ®Google Scholar
• Zvolensky M, Bernstein A, Sachs-Ericsson N, Schmidt N, Buckner J, Bonn-Miller M. Lifetime associations between cannabis use, abuse, and dependence and panic attacks in a representative sample. J Psychiatry Res 2006;40:477–486
   PubMed Web of Science ®Google Scholar
• Zvolensky M, Lewinsohn P, Bernstein A, Schmidt N, Buckner J, Seeley J, Bonn-Miller MO. Prospective associations between cannabis use, abuse and dependence and panic attacks and disorder. J Psychiatry Res 2008;42:1017–1023
   PubMed Web of Science ®Google Scholar
• Johnson K, Mullin J, Marshall E, Bonn-Miller M, Zvolensky M. Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. Am J Addict 2010;19:277–282
   PubMed Web of Science ®Google Scholar
• Zvolensky M, Vujanovic A, Bernstein A, Bonn-Miller M, Marshall E, Leyro T. Marijuana use motives: a confirmatory test and evaluation among young adult marijuana users. Addict Behav 2007;32:3122–3130
   PubMed Web of Science ®Google Scholar
• Bonn-Miller M, Zvolensky M. An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addict 2009;18:409–416
   PubMed Web of Science ®Google Scholar
• Bonn-Miller M, Zvolensky M, Bernstein A. Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers. Addict Behav 2007;32:49–62
   PubMed Web of Science ®Google Scholar
• Bonn-Miller M. The Medical Marijuana Patient Use Questionnaire. Unpublished manuscript 2012
   Google Scholar
• First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Non-Patient Edition. New York: New York State Psychiatric Institute; 1995
   Google Scholar
• Budney A, Hughes J, Moore B, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004;161:1967–1977
   PubMed Web of Science ®Google Scholar
• Adamson S, Kay-Lambkin F, Baker A, Lewin T, Thornton L, Kelly B, Sellman JD. An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend 2010;110:137–143
   PubMed Web of Science ®Google Scholar
• Saunders J, Aasland O, Babor T, de la Fuente J, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption: II. Addiction 1993;88:791–804
   PubMed Web of Science ®Google Scholar
• Bonn-Miller M, Zvolensky M, Johnson K. Uni-morbid and co-occurring marijuana and tobacco use: examination of concurrent associations with negative mood states. J Addict Dis 2010;29:68–77
   PubMed Web of Science ®Google Scholar
• Hubbard R, Marsden M, Rachal J, Harwood H, Cavanaugh E, Ginzburg H. Drug abuse treatment: a national study of effectiveness. Chapel Hill (NC): University of North Carolina Press; 1989
   Google Scholar
• Bonn-Miller M, Moos R. Marijuana discontinuation, anxiety symptoms, and relapse to marijuana. Addict Behav 2009;34:782–785
   PubMed Web of Science ®Google Scholar
• Watson D, O’Hara M, Simms L, Kotov R, Chmielewski M, McDade-Montez E, Gamez W, Stuart S. Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS). Psychol Assess 2007;19:253–268
   PubMed Web of Science ®Google Scholar
• Watson D, Chmielewski M, McDade-Montez E, Koffel E, Naragon K, Stuart, S. Further validation of the IDAS: evidence of convergent, discriminant, criterion, and incremental validity. Psychol Assess 2008;20:248–259
   PubMed Web of Science ®Google Scholar
• Jensen M, Turner J, Romano J, Fisher L. Comparative reliability and validity of chronic pain intensity measures. Pain 1999;83:157–162
   PubMed Web of Science ®Google Scholar
• Lee C, Neighbors C, Hendershot C, Grossbard J. Development and preliminary validation of a Comprehensive Marijuana Motives Questionnaire. J Stud Alcohol Drugs 2009;70:279–287
   PubMed Web of Science ®Google Scholar
• Rohde P, Lewinsohn P, Seeley J. Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. J Abnorm Psychol 1991;100:214–222
   PubMed Web of Science ®Google Scholar
• Mineka S, Watson D, Clark L. Comorbidity of anxiety and unipolar mood disorders. Ann Rev Psychol 1998;49:377–412
   PubMed Web of Science ®Google Scholar
• Turk D, Okifuji A. Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 2002;70:678–690
   PubMed Web of Science ®Google Scholar
• McWilliams L, Cox B, Enns M. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 2003;106:127–133
   PubMed Web of Science ®Google Scholar
• Potter D, Clark P, Brown M. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 2005;53:90–94
   Google Scholar
• Starks M. Marijuana chemistry: genetics, processing, potency. Oakland, CA: Ronin Publishing; 1993
   Google Scholar
• Bergamaschi M, Querioz R, Chagas M, de Oliveira D, de Martinis B, Kapczinski F, Quevedo J, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacol 2011;36:1219–1226
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Mishima K, Nozako M, Ogata A, Hazekawa M, Liu AX, Fujioka M, Abe K. Repeated treatment with cannabidiol but not delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacol 2007;52:1079–1087
   PubMedGoogle Scholar
• Malone D, Jongejan D, Taylor D. Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats. Pharmacol Biochem Behav 2009;93:91–96
   PubMed Web of Science ®Google Scholar
• Tanda G, Goldberg S. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacol 2003;169:115–134
   PubMedGoogle Scholar
• Booz G. Cannabidiol as an emergence therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med 2011;51:1054–1061
   PubMed Web of Science ®Google Scholar
• Nicholson A, Turner C, Stone B, Robson P. Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 2004;24:305–313
   PubMed Web of Science ®Google Scholar
• Rock E, Bolognini D, Limebeer C, Cascio M, Anavi-Goffer S, Fletcher P, Mechoulam R, et al. Cannabidiol, a non-psychotropic compenent of cannabis, attenuates vomiting and nausea-like behavior via indirect agaonism of f-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol 2012;165:2620–2634
   PubMed Web of Science ®Google Scholar
• Zuardi A, Morais S, Guimaraes F, Mechoulam R. Antipsychotic effect of cannabidiol. J Clin Psychiatry 1995;56:485–486
   PubMed Web of Science ®Google Scholar
• Compton W, Grant B, Colliver J, Glantz M, Stinson F. Prevalence of marijuana use disorders in the United States. JAMA 2004;291:2114–2121
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington, DC: American Psychiatric Association; 2013
   Google Scholar
• Chubineh S, McGowan J. Nausea and vomiting in HIV: a symptom review. Int J STD AIDS 2008;19:723–728
   PubMed Web of Science ®Google Scholar
• Parker L, Mechoulam R, Schlievert C. Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats. NeuroReport 2002;13:567–570
   PubMed Web of Science ®Google Scholar
• Metrik J, Rohsenow D, Monti P, McGeary J, Cook T, deWit H, Haney M, Kahler C. Effectiveness of a marijuana expectancy manipulation: piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol 2009;17:217–225
   PubMed Web of Science ®Google Scholar
• Brisbois T, de Kock I, Watanabe S, Mirhosseini M, Lamoureux D, Chasen M, MacDonald N, et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 2011;22:2086–2093
   PubMed Web of Science ®Google Scholar
• Shierenbeck T, Reimann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev 2008;12:381–389
   PubMedGoogle Scholar
• Beautrais A, Joyce P, Mulder R. Cannabis abuse and serious suicide attempts. Addiction 1999;94:1155–1164
   PubMed Web of Science ®Google Scholar
• Price C, Hemmingsson T, Lewis G, Zammit S, Allebeck P. Cannabis and suicide: longitudinal study. Br J Psychiatry 2009;195:492–497
   PubMed Web of Science ®Google Scholar
• Bonn-Miller M, Vujanovic A, Feldner M, Bernstein A, Zvolensky M. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. J Trauma Stress 2007;20:577–586
   PubMed Web of Science ®Google Scholar
• Fergusson D, Boden J. Cannabis use and later life outcomes. Addiction 2008;103:969–976
   PubMed Web of Science ®Google Scholar
• Looby A, Earleywine M. Negative consequences associated with dependence in daily cannabis users. Subst Abuse Treat Prev Policy 2007;2:3
   PubMed Web of Science ®Google Scholar
• Babson K, Boden M, Harris A, Stickle T, Bonn-Miller M. Poor sleep quality as a risk factor for lapse following a cannabis quit attempt. J Subst Abuse Treat 2013;44:438–443
   PubMed Web of Science ®Google Scholar
• Bonn-Miller M, Babson K, Vujanovic A, Feldner M. Sleep problems and PTSD symptoms interact to predict marijuana use coping motives: a preliminary investigation. J Dual Diagn 2010;6:111–122
   Web of Science ®Google Scholar
• Buckner J, Bonn-Miller M, Zvolensky M, Schmidt N. Marijuana use motives and social anxiety among marijuana using young adults. Addict Behav 2007;32:2238–2252
   PubMed Web of Science ®Google Scholar
• Buckner J, Heimberg R, Matthews R, Silgado J. Marijuana-related problems and social anxiety: the role of marijuana behaviors in social situations. Psychol Addict Behav 2012;26:151–156
   PubMed Web of Science ®Google Scholar
• Buckner J, Crosby R, Silgado J, Wonderlich S, Schmidt N. Immediate antecedents of marijuana use: an analysis from ecological momentary assessment. J Behav Ther Exp Psychiatry 2012;43:647–266
   PubMed Web of Science ®Google Scholar